The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
QUINSTREET INC | COM | 74874Q100 | 1,015 | 270,114 | SH | SOLE | 270,114 | 0 | 0 | ||
FIDUS INVT CORP | COM | 316500107 | 4,091 | 260,105 | SH | SOLE | 260,105 | 0 | 0 | ||
TRANSENTERIX INC | COM NEW | 89366M201 | 3,942 | 3,032,625 | SH | SOLE | 3,032,625 | 0 | 0 | ||
HALLADOR ENERGY COMPANY | COM | 40609P105 | 87 | 9,641 | SH | SOLE | 9,641 | 0 | 0 | ||
CAESARS ENTMT CORP | COM | 127686103 | 14,152 | 1,665,032 | SH | SOLE | 1,665,032 | 0 | 0 | ||
CAESARS ACQUISITION CO | CL A | 12768T103 | 22,477 | 1,665,032 | SH | SOLE | 1,665,032 | 0 | 0 | ||
NOVOCURE LTD | ORD SHS | G6674U108 | 14,251 | 1,815,479 | SH | SOLE | 1,815,479 | 0 | 0 | ||
FIRST DATA CORP NEW | COM CL A | 32008D106 | 22,446 | 1,581,821 | SH | SOLE | 1,581,821 | 0 | 0 |